BGI Genomics Monthly Spotlight - November 2024
BGI Genomics
BGI Genomics, based in China, is the world’s leading provider of genetic tests and sequencing services.
Peruvian Engineer Drawn to Shenzhen by Its Natural Charm and Urban Vibrancy
CGTN interviewed our Peruvian Field Service Engineer Christian Virrueta. During the interview, he shares insights into BGI Genomics’ establishment of its first clinical laboratory in Latin America, marking a significant milestone in advancing healthcare across the region.
?He emphasized the critical role of collaboration and shared development between China and Peru in fostering innovation and progress in the field of life science.
Research Proves Stool DNA as Non-Invasive Alternative for Colorectal Cancer Screening
A prospective cross-section study which was published in Asian Pacific Journal of Cancer Prevention, by BGI Genomics and Siriraj Hospital demonstrates high accuracy of multi-target stool DNA testing for colorectal cancer detection in Thai individuals, offering a non-invasive screening alternative to colonoscopy.
New Classification of Gastrointestinal Stromal Tumors Guides Precision Treatment
BGI Genomics and partners have published a transformative study in Nature Communications that links genetic differences in Gastrointestinal Stromal Tumors (GISTs) to tailored treatment strategies. The discovery of YLPM1 as a tumor suppressor gene marks a significant step in precision oncology.
New Large-Scale Cohort Study Identifies Diverse Pregnancy Health Atlas in China?
A new pregnancy health cohort study, led by BGI Genomics in collaboration with medical centers from 12 Chinese cities and published in the?European Journal of Epidemiology?in November 2024, identifies common pregnancy complications, high-risk groups, and geographical trends in China.
International Experts United in Tashkent to Tackle Rare Disease for Uzbekistan
At the recent "Commonwealth Without Borders" forum in Tashkent, global experts convened to address the pressing challenge of rare diseases in Uzbekistan, where BGI Genomics, alongside our JV Genscreen lab, hosted a satellite session titled "Modern Approaches in the Diagnosis of Rare Diseases – Experience of BGI Genomics."
"I've broken the inheritance chain of thalassemia" -Survivor Story of Stanley
Stanley, diagnosed with thalassemia at just 8 months old, he has relied on regular blood transfusions to survive for 35 years. Before married, his wife got screened first, the result showed she isn’t a carrier. Now he urges individuals in Indonesia to take control of their future through genetic screening.